Scarica l'app Stockscreener
16.44
3.40%
0.54
Dopo l'orario di chiusura:
16.44
Precedente Chiudi:
$15.90
Aprire:
$15.99
Volume 24 ore:
461.65K
Relative Volume:
1.00
Capitalizzazione di mercato:
$513.43M
Reddito:
$322.67M
Utile/perdita netta:
$-61.63M
Rapporto P/E:
-8.3647
EPS:
-1.9654
Flusso di cassa netto:
$-124.21M
1 W Prestazione:
-1.38%
1M Prestazione:
+7.24%
6M Prestazione:
-30.04%
1 anno Prestazione:
-5.03%
Intervallo 1D:
$15.91
$16.48
Intervallo di 1 settimana:
$15.39
$16.84
Portata 52W:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
16.44 | 496.57M | 322.67M | -61.63M | -124.21M | -1.9654 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, ... - Bluefield Daily Telegraph
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Dow Update: What are Fulgent Genetics Incs technical support levelsWeekly Stock Analysis & Risk Managed Investment Signals - baoquankhu1.vn
Aug Volume: What is the long term forecast for Fulgent Genetics Inc stockWeekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
JPMorgan Chase & Co. Increases Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc - ACCESS Newswire
Fulgent Genetics (NASDAQ: FLGT) CEO cancels 750,000-share prepaid forward - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CEO reports 30.7% ownership stake - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) outlines 2026 meeting, pay and equity plan votes - Stock Titan
Fulgent Genetics (FLGT) price target decreased by 27.72% to 24.82 - MSN
Technical Reactions to FLGT Trends in Macro Strategies - news.stocktradersdaily.com
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Rises By 38.7% - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc. - lincolnjournal.com
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent ... - Bluefield Daily Telegraph
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
If You Invested $1,000 in Fulgent Genetics (FLGT) - Stock Titan
Aug Weekly: How is Fulgent Genetics Inc managing supply chain issues2026 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - The Chronicle-Journal
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Trading the Move, Not the Narrative: (FLGT) Edition - news.stocktradersdaily.com
Published on: 2026-03-19 03:58:12 - baoquankhu1.vn
Fulgent Genetics Completes $56.9M Acquisition of Bako Diagnostics and StrataDx to Expand Precision Medicine Services - Minichart
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics completes $56.9M pathology lab acquisitions By Investing.com - Investing.com Australia
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Fulgent Genetics Acquires Bako Diagnostics Assets, StrataDx for $56.9 Million - marketscreener.com
Fulgent Genetics completes $56.9M pathology lab acquisitions - Investing.com
Fulgent Genetics Expands Dermatology Footprint With Key Acquisitions - TipRanks
Fulgent Genetics (NASDAQ: FLGT) buys Bako Diagnostics and StrataDx - Stock Titan
Fulgent Genetics (NASDAQ:FLGT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail
Fulgent Genetics, Inc. agreed to acquire Strata Pathology Services Inc. on December 22, 2025. A cash consideration will be paid by Fulgent Genetics, Inc. As part of consideration, an undisclosed value is paid towards None of Strata Pathology Services Inc. - marketscreener.com
Fulgent Genetics (FLGT) Stock Analysis Report | Financials & Insights - Benzinga España
Fulgent Genetics seeks new collaborations at Copenhagen ADPD2026 event - Traders Union
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire
Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT) - Seeking Alpha
Fulgent Genetics (NASDAQ: FLGT) CEO pays $10.7M to cancel share forward - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - caledonianrecord.com
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
Aug Sectors: Should I hold or sell Fulgent Genetics Inc now2026 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
Fulgent Genetics Hits New 52-Week Low at $14.01 Amid Declining Performance - Markets Mojo
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Technical Analysis: Is Fulgent Genetics Inc a top pick in the sectorQuarterly Earnings Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Fulgent Genetics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-03-05 - Seeking Alpha
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - FinancialContent
FLGT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics (FLGT) CSO has shares withheld to cover RSU taxes - Stock Titan
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):